Michael F. Chiang | |
---|---|
Education | Stanford University (BS) Harvard University (MD) Columbia University (MA) |
Scientific career | |
Fields | Pediatric ophthalmology |
Institutions | Columbia University Oregon Health & Science University National Eye Institute |
Michael F. Chiang is an American pediatric ophthalmologist serving as the director of the National Eye Institute. His research focuses on the interface of biomedical informatics and clinical ophthalmology in areas such as retinopathy of prematurity (ROP), telehealth, artificial intelligence, electronic health records, data science, and genotype-phenotype correlation.
Chiang received a B.S. in Electrical Engineering and Biology from Stanford University, an M.D. from Harvard Medical School and the Harvard–MIT Program in Health Sciences and Technology, and an M.A. in Biomedical Informatics from Columbia University. He completed residency and pediatric ophthalmology fellowship training at the Wilmer Eye Institute. [1]
Between 2001-2010, he worked at Columbia University, where he was Anne S. Cohen Associate Professor of Ophthalmology & Biomedical Informatics, director of medical student education in ophthalmology, and director of the introductory graduate student course in biomedical informatics. [1] From 2010-2020, he worked at Oregon Health & Science University (OHSU), where he was Knowles Professor of Ophthalmology & Medical Informatics and Clinical Epidemiology, and Associate Director of the Casey Eye Institute. [1] He co-directed a National Institutes of Health (NIH) funded T32 training program in visual science for graduate students and research fellows, as well as an NIH-funded K12 clinician-scientist program at OHSU. [1]
Chiang began at the NIH in November 2020 as director of the National Eye Institute. His research focuses on the interface of biomedical informatics and clinical ophthalmology in areas such as retinopathy of prematurity (ROP), telehealth, artificial intelligence, electronic health records, data science, and genotype-phenotype correlation. [1]
Chiang was elected to the National Academy of Medicine in 2023. [2]
Retinopathy is any damage to the retina of the eyes, which may cause vision impairment. Retinopathy often refers to retinal vascular disease, or damage to the retina caused by abnormal blood flow. Age-related macular degeneration is technically included under the umbrella term retinopathy but is often discussed as a separate entity. Retinopathy, or retinal vascular disease, can be broadly categorized into proliferative and non-proliferative types. Frequently, retinopathy is an ocular manifestation of systemic disease as seen in diabetes or hypertension. Diabetes is the most common cause of retinopathy in the U.S. as of 2008. Diabetic retinopathy is the leading cause of blindness in working-aged people. It accounts for about 5% of blindness worldwide and is designated a priority eye disease by the World Health Organization.
The National Eye Institute (NEI) is part of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. The mission of NEI is "to eliminate vision loss and improve quality of life through vision research." NEI consists of two major branches for research: an extramural branch that funds studies outside NIH and an intramural branch that funds research on the NIH campus in Bethesda, Maryland. Most of the NEI budget funds extramural research.
Retinopathy of prematurity (ROP), also called retrolental fibroplasia (RLF) and Terry syndrome, is a disease of the eye affecting prematurely born babies generally having received neonatal intensive care, in which oxygen therapy is used because of the premature development of their lungs. It is thought to be caused by disorganized growth of retinal blood vessels and may result in scarring and retinal detachment. ROP can be mild and may resolve spontaneously, but it may lead to blindness in serious cases. Thus, all preterm babies are at risk for ROP, and very low birth-weight is an additional risk factor. Both oxygen toxicity and relative hypoxia can contribute to the development of ROP.
The University of Tennessee Health Science Center (UTHSC) is a public medical school in Memphis, Tennessee. It includes the Colleges of Health Professions, Dentistry, Graduate Health Sciences, Medicine, Nursing, and Pharmacy. Since 1911, the University of Tennessee Health Science Center has educated nearly 57,000 health care professionals. As of 2010, U.S. News & World Report ranked the College of Pharmacy 17th among American pharmacy schools.
Oregon Health & Science University (OHSU) is a public research university focusing primarily on health sciences with a main campus, including two hospitals, in Portland, Oregon. The institution was founded in 1887 as the University of Oregon Medical Department and later became the University of Oregon Medical School. In 1974, the campus became an independent, self-governed institution called the University of Oregon Health Sciences Center, combining state dentistry, medicine, nursing, and public health programs into a single center. It was renamed Oregon Health Sciences University in 1981 and took its current name in 2001, as part of a merger with the Oregon Graduate Institute (OGI), in Hillsboro. The university has several partnership programs including a joint PharmD Pharmacy program with Oregon State University in Corvallis.
Dilated fundus examination (DFE) is a diagnostic procedure that uses mydriatic eye drops to dilate or enlarge the pupil in order to obtain a better view of the fundus of the eye. Once the pupil is dilated, examiners use ophthalmoscopy to view the eye's interior, which makes it easier to assess the retina, optic nerve head, blood vessels, and other important features. DFE has been found to be a more effective method for evaluating eye health when compared to non-dilated examination, and is the best method of evaluating structures behind the iris. It is frequently performed by ophthalmologists and optometrists as part of an eye examination.
Russ Biagio Altman is an American professor of bioengineering, genetics, medicine, and biomedical data science and past chairman of the bioengineering department at Stanford University.
Joseph E. Robertson Jr. is an American ophthalmologist who was the president of Oregon Health & Science University in Portland, Oregon from September 2006 to July 2018.
The University of Utah School of Medicine is located on the upper campus of the University of Utah in Salt Lake City, Utah. It was founded in 1905 and is currently the only MD-granting medical school in the state of Utah.
Joan S. Ash is Professor and Vice Chair, Department of Medical Informatics and Clinical Epidemiology, School of Medicine, Oregon Health & Science University (OHSU), Portland, OR. She holds master's degrees in library science Columbia University, health science, and business administration Portland State University. Her doctorate is in Systems Science: Business Administration from Portland State. She is currently the Chair of the Board of Scientific Counselors for the Lister Hill National Center for Biomedical Communications. She has served on the Boards of Directors of the American Medical Informatics Association, the Medical Library Association, and on the United States National Library of Medicine's Biomedical Library and Informatics Review Committee. She is co-author of Clinical Information Systems: Overcoming Adverse Consequences.
Teleophthalmology is a branch of telemedicine that delivers eye care through digital medical equipment and telecommunications technology. Today, applications of teleophthalmology encompass access to eye specialists for patients in remote areas, ophthalmic disease screening, diagnosis and monitoring; as well as distant learning.
Christopher G. Chute is a Bloomberg Distinguished Professor at Johns Hopkins University, physician-scientist and biomedical informatician known for biomedical terminologies and health information technology (IT) standards. He chairs the World Health Organization Revision Steering Group for the revision of the International Classification of Diseases (ICD-11).
Childhood blindness is an important contribution to the national prevalence of the disability of blindness. Blindness in children can be defined as a visual acuity of <3/60 in the eye with better vision of a child under 16 years of age. This generally means that the child cannot see an object 10 feet away, that another child could see if it was 200 feet away.
Yog Raj Sharma is an Indian ophthalmologist and ex-chief of Dr. Rajendra Prasad Centre for Ophthalmic Sciences of the All India Institute of Medical Sciences (AIIMS), New Delhi, the apex body of the National Programme for the Control of Blindness, a Government of India initiative to reduce the prevalence of blindness in India. He is the Chairman of the Task Force on Prevention and Control of Diabetic Retinopathy Group and the Co-Chairman of the National Task Force on Prevention of Blindness from Retinopathy of Prematurity under the Ministry of Health and Family Welfare of the Government of India. An advisor to the Ministry of Health and Family Welfare, India. Sharma was honored by the Government of India in 2015 with Padma Shri, the fourth highest Indian civilian award. In 2005, Yog Raj Sharma's published article on "Pars plana vitrectomy vs scleral buckling in rhegmatogenous retinal detachment" in Acta Ophthalmologica Scandinavica and in November 2021, American society of retina specialists cited it as top 100 publications on retinal detachment management in the last ~121 years. Of these top hundred publications, only nineteen countries contributed, three of the contributing countries were Asian and from India this study was the sole contribution. Dr Sharma called it 'the singular biggest achievement of his career" in an article published in Daily Excelsior, Jammu in December 2021.
Rohit Varma is an Indian-American ophthalmologist and professor of ophthalmology and preventive medicine. In 2014, he was named director of the USC Eye Institute and chairman of the Department of Ophthalmology for Keck School of Medicine of USC. In March 2016, Varma was named the interim dean of the Keck School of Medicine, and in November was named dean. In October 2017, USC announced that he stepped down as dean. In October 2018, Varma became the founding director of the Southern California Eyecare and Vision Research Institute.
Clare Gilbert is a British ophthalmologist, professor and researcher who focuses on blindness in children. She is based at the London School of Hygiene and Tropical Medicine (LSHTM).
Dr. William Tasman (1929–2017) an American ophthalmologist, was the ophthalmologist-in-chief at Wills Eye Hospital His work had a profound impact on the treatment of retinopathy of prematurity (ROP). He served as the president of the American Academy of Ophthalmology, the president of the American Ophthalmological Society, the president of the Retina Society, the editor for Duane's Clinical Ophthalmology, and the editor for Survey of Ophthalmology,
Janine Austin Clayton is an American ophthalmologist. She is the NIH associate director for research on women's health and director of the Office of Women's Health. Clayton was previously the deputy clinical director of the National Eye Institute.
Adrienne Williams Scott is an American ophthalmologist specialized in diabetic retinopathy, epiretinal membranes, and macular degeneration. She is chief of the Wilmer Eye Institute in Bel Air, Harford County, Maryland. She is an associate professor of ophthalmology at Johns Hopkins School of Medicine.